Insmed | INSM - Pre Tax Profit

Stock Price
149.86
Daily Change
-1.17 -0.77%
Monthly
-14.85%
Yearly
87.44%
Q1 Forecast
152.04

Insmed reported $-368.7M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
BioMarin Pharmaceutical USD -26.32M 324.19M Sep/2025
Cytokinetics USD -306.18M 171.81M Sep/2025
DBV Technologies USD -33.16M 8.6M Sep/2025
Dynavax Technologies USD 28.42M 7.2M Sep/2025
Gilead Sciences USD 2.43B 780M Jun/2025
Insmed USD -368.7M 48.26M Sep/2025
Novartis USD 5.17B 637M Sep/2025
Regeneron Pharmaceuticals USD 1.76B 244.6M Sep/2025
Sarepta Therapeutics USD -194.05M 347.69M Sep/2025
Ultragenyx Pharmaceutical USD -179.54M 65.54M Sep/2025
Vertex Pharmaceuticals USD 1.3B 15.8M Sep/2025